Inovio Pharmaceuticals, Inc

(NASDAQ:INO)

Latest On Inovio Pharmaceuticals, Inc (INO):

Date/Time Type Description Signal Details
2023-05-24 03:50 ESTNewsInovio wins orphan drug status for HPV-related candidate in EuropeN/A
2023-05-18 07:17 ESTNewsInovio Pharmaceuticals, Inc. (INO) 2023 RBC Capital Markets Global Healthcare Conference (Transcript)N/A
2023-05-17 18:36 ESTNewsInovio Corporate PresentationN/A
2023-05-11 06:41 ESTNewsInovio Pharmaceuticals, Inc. (INO) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 17:08 ESTNewsInovio Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $0.11M misses by $0.17MN/A
2023-05-10 04:00 ESTNewsInovio Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-26 18:55 ESTNewsInovio's respiratory disorder therapy on way to get orphan drug status in EUN/A
2023-04-17 22:45 ESTNewsInovio gains on Phase 1 data for Ebola booster shotN/A
2023-04-04 16:10 ESTNewsInovio: Adrift At A Bargain Price But No Near-Term CatalystN/A
2023-03-14 06:00 ESTNewsInovio Pharmaceuticals, Inc. (INO) Oppenheimer 33rd Annual Healthcare Conference (Transcript)N/A
2023-03-02 17:57 ESTNewsInovio stock rises amid mixed trial results for cervical lesions drug; Q4 clinical updatesN/A
2023-03-02 03:13 ESTNewsInovio Pharmaceuticals GAAP EPS of -$1.17 misses by $0.06, revenue of $10.26M misses by $0.29MN/A
2023-03-02 03:13 ESTNewsInovio Pharmaceuticals, Inc. (INO) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 21:36 ESTNewsInovio Pharmaceuticals FY 2022 Earnings PreviewN/A
2023-01-31 16:52 ESTNewsInovio in strategic reorganization; 11% headcount reductionN/A
2023-01-10 08:57 ESTNewsInovio: Hold For Future DNA Plasmid Therapy ProgressN/A
2022-11-17 22:53 ESTNewsInovio ends development of candidates for Lassa fever and Middle East Respiratory SyndromeN/A
2022-11-10 01:41 ESTNewsInovio Pharmaceuticals stock rises on Q3 profit beat, raised cash runway guidanceN/A
2022-11-09 07:26 ESTNewsInovio Pharmaceuticals GAAP EPS of -$0.15 beats by $0.15, revenue of $9.15MN/A
2022-11-09 07:25 ESTNewsInovio Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-09 07:25 ESTNewsInovio Pharmaceuticals, Inc. (INO) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 20:30 ESTNewsInovio Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-10-28 02:30 ESTNewsInovio Pharmaceuticals stops development of COVID-19 booster shot candidateN/A
2022-10-24 23:11 ESTNewsInovio Pharmaceuticals: Catalysts On The HorizonN/A
2022-10-13 12:26 ESTNewsInovio reports positive phase 1/2 results for recurrent respiratory papillomatosis drugN/A
2022-09-27 12:45 ESTNewsInovio Pharmaceuticals: Long On Promise, Short On ResultsN/A
2022-09-12 19:28 ESTNewsInovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)N/A
2022-08-10 01:47 ESTNewsInovio Pharmaceuticals GAAP EPS of -$0.46 misses by $0.15, revenue of $0.78M beats by $0.26MN/A
2022-08-10 01:47 ESTNewsInovio beats on the top line but misses on the bottom; quarterly net loss widens 32%N/A
2022-08-10 01:46 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Jacqueline Shea on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 03:59 ESTNewsInovio Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-19 18:54 ESTNewsInovio to cut workforce by 18% as part of corporate reorganizationN/A
2022-07-19 18:54 ESTNewsInovio Pharmaceuticals slotted at Sector Perform by RBC Capital in initial rating lookN/A
2022-07-19 04:14 ESTNewsInovio: After All These YearsN/A
2022-06-27 10:13 ESTNewsINOVIO appoints Dr. Michael Sumner as CMON/A
2022-06-08 20:43 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Jacqui Shea Present at Jefferies 2022 Global Healthcare Conference (Transcript)N/A
2022-05-27 21:55 ESTNewsInovio announces positive survival results from trial testing glioblastoma treatmentN/A
2022-05-12 00:50 ESTNewsInovio downgraded at Oppenheimer as CEO departure adds uncertaintyN/A
2022-05-11 05:04 ESTNewsJacqueline Shea named new CEO of InovioN/A
2022-05-11 05:04 ESTNewsInovio Pharmaceuticals Non-GAAP EPS of -$0.36, revenue of $0.2MN/A
2022-05-11 05:04 ESTNewsInovio Pharmaceuticals falls 20% on Q1 misses, announcement of new CEON/A
2022-05-11 05:04 ESTNewsInovio Pharmaceuticals, Inc. (INO) on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 07:30 ESTNewsInovio Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-15 14:34 ESTNewsInovio: Long-Term Biotech To Own With Several Catalysts Expected In 2022N/A
2022-03-16 03:16 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Oppenheimer's 32nd Annual Healthcare Conference (Transcript)N/A
2022-03-02 18:57 ESTNewsInovio Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 18:57 ESTNewsInovio COVID vaccine weaker vs Omicron in lab test; phase 3 trial enrollment pausedN/A
2022-03-02 02:32 ESTNewsInovio Pharmaceuticals GAAP EPS of -$1.45 misses by $0.19, revenue of $1.77M beats by $0.31MN/A
2022-03-02 02:32 ESTNewsInovio Pharmaceuticals results miss on the bottom line; shares down 9%N/A
2022-03-02 02:31 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Dr. Joseph Kim on Q4 2021 Results - Earnings Call TranscriptN/A

About Inovio Pharmaceuticals, Inc (INO):

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquart

See Advanced Chart

General

  • Name Inovio Pharmaceuticals, Inc
  • Symbol INO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 262
  • Last Split Factor1:4
  • Last Split Date2014-06-06
  • Fiscal Year EndDecember
  • IPO Date1998-02-12
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.inovio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 221.24
  • Price/Book (Most Recent Quarter) 4.76
  • Enterprise Value Revenue 245.85
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.59
  • Next Year EPS Estimate $0.25
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -1674%
  • Return on Assets -23%
  • Return on Equity -72%
  • Revenue 7.41 million
  • Earnings Per Share -$1.22
  • Revenue Per Share $0.05
  • Gross Profit -86834216
  • Quarterly Earnings Growth 1896.7%
View More

Highlights

  • Market Capitalization 2.15 billion
  • EBITDA -108041976
  • PE Ratio -1.54
  • Analyst Target Price $16
  • Book Value Per Share $2.47
View More

Share Statistics

  • Shares Outstanding 207.63 million
  • Shares Float 204.08 million
  • % Held by Insiders 217%
  • % Held by Institutions 36.49%
  • Shares Short 50.23 million
  • Shares Short Prior Month 43.09 million
  • Short Ratio 2.19
  • Short % of Float 25%
  • Short % of Shares Outstanding 24%
View More

Technicals

  • Beta 0.97
  • 52 Week High $33.79
  • 52 Week Low $6.5
  • 50 Day Moving Average 12.08
  • 200 Day Moving Average 11.47
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Inovio Pharmaceuticals, Inc (INO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Inovio Pharmaceuticals, Inc (INO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.11-$0.2250.85%
2020-09-302020-11-09$N/A$0.11-$0.19158.26%
2020-06-302020-08-10$N/A-$0.83-$0.17-391.71%
2020-03-312020-05-11$1.33 million-$0.26-$0.23-15.56%
2019-12-312020-03-12$279488-$0.38-$0.24-59.26%
2019-09-302019-11-12$866863-$0.23-$0.257.37%
2019-06-302019-08-08$135673-$0.30-$0.28-6.04%
2019-03-312019-05-09$2.83 million-$0.30-$0.26-15.38%
2018-12-312019-03-12$2.5 million-$0.34-$0.29-15.65%
2018-09-302018-11-08$2 million-$0.27-$0.3113.46%
2018-06-302018-08-07$24.45 million-$0.07-$0.2773.58%
2018-03-312018-05-09$1.53 million-$0.36-$0.08-350%
2017-12-312018-03-14$8.79 million-$0.23-$0.3022.48%
2017-09-302017-11-08$2.65 million-$0.39-$0.26-52.94%
2017-06-302017-08-08$20.41 million-$0.13-$0.1932.29%
2017-03-312017-05-10$10.38 million-$0.31-$0.310.8%
2016-12-312017-03-15$8.51 million-$0.35-$0.33-7.69%
2016-09-302016-11-09$12.54 million-$0.28-$0.27-4.48%
2016-06-302016-08-08$6.2 million-$0.26-$0.21-26.21%
2016-03-312016-05-09$8.11 million-$0.11-$0.2352.17%
2015-12-312016-03-14$5.94 million-$0.25-$0.21-21.95%
2015-09-302015-11-09$24.18 million$0.07$0.0475%
2015-06-302015-08-10$5.29 million-$0.09-$0.1330.77%
2015-03-312015-05-11$5.17 million-$0.17-$0.11-54.55%
2014-12-312015-03-16$2.46 million-$0.12-$0.10-20%
2014-09-302014-11-10$1.84 million-$0.12-$0.1414.29%
2014-06-302014-08-11$3.8 million-$0.18-$0.195.26%
2014-03-312014-05-12$2.36 million-$0.20-$0.16-25%
2013-12-312014-03-17$1.74 million-$0.28-$0.14-100%
2013-09-302013-11-12$9.49 million-$0.64-$0.10-540%
2013-06-302013-08-09$786000-$0.24-$0.14-71.43%
2013-03-312013-05-10$1.46 million-$0.24-$0.17-41.18%
2012-12-312013-03-18$1.14 million-$0.02-$0.1889.61%
2012-09-302012-11-07$855000-$0.20-$0.14-42.86%
2012-06-302012-08-09$436000-$0.12-$0.1729.41%
2012-03-312012-05-09$1.69 million-$0.24-$0.18-33.33%
2011-12-312012-03-15$1.63 million-$0.16-$0.2020%
2011-09-302011-11-07$2.64 million-$0.16-$0.13-23.08%
2011-06-302011-08-08$2.42 million-$0.08-$0.1957.89%
2011-03-312011-05-11$3.11 million-$0.08-$0.1546.67%
2010-12-312011-03-17$2.36 million-$0.28-$0.15-86.67%
2010-09-302010-11-15$1.28 million-$0.04-$0.1163.64%
2010-06-302010-08-16$1.13 million-$0.28-$0.08-250%
2010-03-312010-05-17$1.37 million-$0.08-$0.1855.56%
2009-12-312010-03-29$2.61 million-$0.28-$0.16-75%
2009-09-302009-11-16$3.65 million-$0.12-$0.2040%
2009-06-302009-08-19$2.49 million-$0.76-$0.24-216.67%
2009-03-312009-05-15$369000-$0.31
2008-12-312009-03-31$327000-$0.32-$0.28-14.29%
2008-09-302008-11-07$455000-$0.20-$0.3847.37%
2008-06-302008-08-07$663000-$0.36-$0.28-28.57%
2008-03-312008-05-09$653000-$0.28-$0.4436.36%
2007-12-312008-03-17$3.32 million-$0.08-$0.4782.98%
2007-09-302007-11-08$487000-$0.44-$0.39-12.82%
2007-06-302007-08-08$495000-$0.44-$0.40-10%
2007-03-312007-05-09$504000-$0.44-$0.37-18.92%
2006-12-312007-03-16$1.53 million-$0.56-$0.43-30.23%
2006-09-302006-11-08$576000-$0.44-$0.40-10%
2006-06-302006-08-08$663000-$0.40-$0.36-11.11%
2006-03-312006-05-09$698000-$0.36-$0.4418.18%
2005-12-312006-03-16$829000-$2.40-$0.64-275%
2005-09-302005-11-09$724000-$0.64-$0.8625.58%
2005-06-302005-08-09$2.95 million-$0.44-$0.9252.17%
2005-03-312005-05-10$962000-$0.88-$0.880%
2004-12-312005-03-15$543000-$0.84-$0.82-2.44%
2004-09-302004-11-15$455000-$0.80-$0.52-53.85%
2004-06-302004-08-09$100000-$0.13
2004-03-312004-05-15$69000-$0.40-$0.6437.5%
2003-12-312004-03-30$39000-$0.48-$0.480%
2003-09-302003-11-12$22000-$2.46
2003-06-302003-07-16$9000-$0.44
2003-03-312003-03-31$11000-$1.23

Inovio Pharmaceuticals, Inc (INO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Inovio Pharmaceuticals, Inc (INO) Chart:

Inovio Pharmaceuticals, Inc (INO) News:

Below you will find a list of latest news for Inovio Pharmaceuticals, Inc (INO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Inovio Pharmaceuticals, Inc (INO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-110.51.28CALL1 0548.34TRUE1.280
2025-04-1110CALL0 01310.63TRUE00
2025-04-111.50.45CALL0 1174.17TRUE00
2025-04-1120.02CALL1 4873.4FALSE-0.03-0.6
2025-04-112.50CALL0 0453.01FALSE00
2025-04-1130CALL0 0517.88FALSE00
2025-04-113.50.05CALL0 1233.48FALSE00
2025-04-1140CALL0 0264.79FALSE00
2025-04-110.50PUT0 0456.41FALSE00
2025-04-1110PUT0 0224.2FALSE00
2025-04-111.50PUT0 083.79FALSE00
2025-04-1120PUT0 0133.55TRUE00
2025-04-112.50PUT0 0939.67TRUE00
2025-04-1130PUT0 0929.23TRUE00
2025-04-113.50PUT0 0955.01TRUE00
2025-04-1140PUT0 0994.75TRUE00
2025-04-170.50CALL0 0505.36TRUE00
2025-04-1710.76CALL0 7430.4TRUE00
2025-04-171.50CALL0 085.55TRUE00
2025-04-1720.3CALL0 786.34FALSE00
2025-04-172.50CALL0 0374.49FALSE00
2025-04-1730.15CALL0 50161.55FALSE00
2025-04-173.50CALL0 0192.98FALSE00
2025-04-1740.1CALL0 659218.89FALSE00
2025-04-1750CALL0 0260.03FALSE00
2025-04-170.50PUT0 01288.75FALSE00
2025-04-1710.05PUT0 1185.63FALSE00
2025-04-171.50PUT0 092.88FALSE00
2025-04-1720.35PUT0 1111.07TRUE00
2025-04-172.50PUT0 0178.83TRUE00
2025-04-1730PUT0 0226.43TRUE00
2025-04-173.50PUT0 0208.25TRUE00
2025-04-1740PUT0 0316.95TRUE00
2025-04-1750PUT0 0342.22TRUE00
2025-04-250.50CALL0 00TRUE00
2025-04-2510CALL0 0871.56TRUE00
2025-04-251.50.25CALL30 049.37TRUE0.250
2025-04-2520CALL0 087.65FALSE00
2025-04-252.50.12CALL0 2124.55FALSE00
2025-04-2530CALL0 0772.81FALSE00
2025-04-253.50CALL0 0161.73FALSE00
2025-04-2540CALL0 0183.47FALSE00
2025-04-250.50PUT0 00FALSE00
2025-04-2510PUT0 00FALSE00
2025-04-251.50PUT0 0519.07FALSE00
2025-04-2520.25PUT0 178.75TRUE00
2025-04-252.50PUT0 0133.22TRUE00
2025-04-2530PUT0 0392.53TRUE00
2025-04-253.50PUT0 0289.68TRUE00
2025-04-2540PUT0 0723.65TRUE00
2025-05-020.50CALL0 00TRUE00
2025-05-0210CALL0 01077.85TRUE00
2025-05-021.50.4CALL0 23108.35TRUE00
2025-05-0220.2CALL0 177.89FALSE00
2025-05-022.50CALL0 0110.83FALSE00
2025-05-0230CALL0 0178.36FALSE00
2025-05-023.50CALL0 0169.24FALSE00
2025-05-0240CALL0 0260.26FALSE00
2025-05-020.50PUT0 01457.18FALSE00
2025-05-0210PUT0 0453.51FALSE00
2025-05-021.50PUT0 085.46FALSE00
2025-05-0220PUT0 084.14TRUE00
2025-05-022.50PUT0 0119.59TRUE00
2025-05-0230PUT0 0577.49TRUE00
2025-05-023.50PUT0 0334.69TRUE00
2025-05-0240PUT0 0674.44TRUE00
2025-05-090.50CALL0 00TRUE00
2025-05-0910CALL0 01212.19TRUE00
2025-05-091.50.28CALL0 10599.98TRUE00
2025-05-0920CALL0 0569.42FALSE00
2025-05-092.50CALL0 0595.31FALSE00
2025-05-0930CALL0 0626.85FALSE00
2025-05-093.50CALL0 0131.02FALSE00
2025-05-090.50PUT0 00FALSE00
2025-05-0910PUT0 00FALSE00
2025-05-091.50PUT0 0693.17FALSE00
2025-05-0920PUT0 0487.61TRUE00
2025-05-092.50PUT0 0394.38TRUE00
2025-05-0930PUT0 0539.58TRUE00
2025-05-093.50PUT0 0566.88TRUE00
2025-05-1610.95CALL0 11269.51TRUE00
2025-05-1620.12CALL0 29465.2FALSE00
2025-05-1630.05CALL10 1692120.66FALSE0.050
2025-05-1640.04CALL0 1143137.3FALSE00
2025-05-1650.05CALL0 891163.21FALSE00
2025-05-1660.05CALL0 122245.56FALSE00
2025-05-1670.03CALL0 240199.78FALSE00
2025-05-1680.03CALL0 215413.32FALSE00
2025-05-1690.05CALL0 162225.56FALSE00
2025-05-16100.15CALL0 1440.98FALSE00
2025-05-16110CALL0 0452.4FALSE00
2025-05-16120.05CALL0 66462.63FALSE00
2025-05-16130.15CALL0 67471.89FALSE00
2025-05-1610.05PUT0 15382.33FALSE00
2025-05-1620.39PUT5 5888.67TRUE0.390
2025-05-1631.24PUT0 13145.97TRUE00
2025-05-1641.93PUT0 0189.91TRUE00
2025-05-1652.77PUT0 49249.84TRUE00
2025-05-1662.45PUT0 28246.22TRUE00
2025-05-1675.1PUT0 8296.38TRUE00
2025-05-1680PUT0 0314.08TRUE00
2025-05-1690PUT0 0258.24TRUE00
2025-05-16104.51PUT0 0343.09TRUE00
2025-05-16110PUT0 0406.07TRUE00
2025-05-16120PUT0 0366.41TRUE00
2025-05-16130PUT0 0303.34TRUE00
2025-08-1510.81CALL0 69072.74TRUE00
2025-08-1520.29CALL0 57979.14FALSE00
2025-08-1530.1CALL0 396979.06FALSE00
2025-08-1540.06CALL1 59797.44FALSE0.060
2025-08-1550.05CALL1 309109.57FALSE0.050
2025-08-1510.05PUT0 2685.91FALSE00
2025-08-1520.55PUT0 9081.09TRUE00
2025-08-1531.13PUT0 5105.66TRUE00
2025-08-1542.05PUT0 3119.04TRUE00
2025-08-1550PUT0 0155.36TRUE00
2025-11-2110.86CALL3 587.43TRUE0.860
2025-11-2120.4CALL2 2186.52FALSE-0.05-0.11
2025-11-2130.2CALL0 471.5FALSE00
2025-11-2140.13CALL0 20272.55FALSE00
2025-11-2150CALL0 091.67FALSE00
2025-11-2110PUT0 076.91FALSE00
2025-11-2120PUT0 091.45TRUE00
2025-11-2130PUT0 089.58TRUE00
2025-11-2140PUT0 0123.17TRUE00
2025-11-2150PUT0 0124.71TRUE00

Latest INO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST500$1.47
Jun 13, 2022 7:59 PM EST5$1.47
Jun 13, 2022 7:59 PM EST100$1.465
Jun 13, 2022 7:59 PM EST500$1.47
Jun 13, 2022 7:59 PM EST100$1.47

Inovio Pharmaceuticals, Inc (INO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm
2018-06-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000018017637/0000000000-18-017637-index.htm
2020-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020001261/0000000000-20-001261-index.htm
2020-03-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020002492/0000000000-20-002492-index.htm
2020-04-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020003215/0000000000-20-003215-index.htm
2020-05-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020003771/0000000000-20-003771-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000021545719004059/0000215457-19-004059-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000081413319000020/0000814133-19-000020-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000081413320000032/0000814133-20-000032-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000083423720005356/0000834237-20-005356-index.htm
2018-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm
2018-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000023/0001055726-18-000023-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572618000026/0001055726-18-000026-index.htm
2018-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/0001055726-18-000027-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/0001055726-18-000028-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000029/0001055726-18-000029-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000030/0001055726-18-000030-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000031/0001055726-18-000031-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000032/0001055726-18-000032-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000033/0001055726-18-000033-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000034/0001055726-18-000034-index.htm
2018-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572618000040/0001055726-18-000040-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572618000045/0001055726-18-000045-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000048/0001055726-18-000048-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/0001055726-18-000049-index.htm
2019-01-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000003/0001055726-19-000003-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000004/0001055726-19-000004-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000006/0001055726-19-000006-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/0001055726-19-000007-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000008/0001055726-19-000008-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000009/0001055726-19-000009-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000012/0001055726-19-000012-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm
2019-03-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000017/0001055726-19-000017-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm
2019-03-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000021/0001055726-19-000021-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000022/0001055726-19-000022-index.htm
2019-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000023/0001055726-19-000023-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000024/0001055726-19-000024-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000025/0001055726-19-000025-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000029/0001055726-19-000029-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000030/0001055726-19-000030-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000031/0001055726-19-000031-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000032/0001055726-19-000032-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000033/0001055726-19-000033-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000034/0001055726-19-000034-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000035/0001055726-19-000035-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000036/0001055726-19-000036-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000037/0001055726-19-000037-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/0001055726-19-000038-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000039/0001055726-19-000039-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000040/0001055726-19-000040-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000041/0001055726-19-000041-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/0001055726-19-000044-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/0001055726-19-000047-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/0001055726-19-000049-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000052/0001055726-19-000052-index.htm
2019-08-15DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000054/0001055726-19-000054-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/0001055726-19-000056-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000058/0001055726-19-000058-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000059/0001055726-19-000059-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000001/0001055726-20-000001-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/0001055726-20-000002-index.htm
2020-01-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000003/0001055726-20-000003-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000004/0001055726-20-000004-index.htm
2020-01-24DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000005/0001055726-20-000005-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1055726/000105572620000012/0001055726-20-000012-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/0001055726-20-000014-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/0001055726-20-000015-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000016/0001055726-20-000016-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/0001055726-20-000017-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000018/0001055726-20-000018-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/0001055726-20-000019-index.htm
2020-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000022/0001055726-20-000022-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000024/0001055726-20-000024-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000025/0001055726-20-000025-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/0001055726-20-000026-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000027/0001055726-20-000027-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000028/0001055726-20-000028-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000029/0001055726-20-000029-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572620000032/0001055726-20-000032-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/0001055726-20-000033-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000034/0001055726-20-000034-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000035/0001055726-20-000035-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000036/0001055726-20-000036-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000037/0001055726-20-000037-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000038/0001055726-20-000038-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000039/0001055726-20-000039-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/0001055726-20-000042-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/0001055726-20-000045-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572620000048/0001055726-20-000048-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/0001055726-20-000049-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000110465920016487/0001104659-20-016487-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000114036120002954/0001140361-20-002954-index.htm
2018-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312518162187/0001193125-18-162187-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312518175305/0001193125-18-175305-index.htm
2018-05-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1055726/000119312518175375/0001193125-18-175375-index.htm
2018-06-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312518185845/0001193125-18-185845-index.htm
2018-06-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312518189390/0001193125-18-189390-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519001663/0001193125-19-001663-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519037998/0001193125-19-037998-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519045422/0001193125-19-045422-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519051968/0001193125-19-051968-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519071917/0001193125-19-071917-index.htm
2019-03-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1055726/000119312519076809/0001193125-19-076809-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519085283/0001193125-19-085283-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519144262/0001193125-19-144262-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519152325/0001193125-19-152325-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519158298/0001193125-19-158298-index.htm
2019-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1055726/000119312519162877/0001193125-19-162877-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519164685/0001193125-19-164685-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519194826/0001193125-19-194826-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519214088/0001193125-19-214088-index.htm
2020-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520000651/0001193125-20-000651-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520008085/0001193125-20-008085-index.htm
2020-01-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1055726/000119312520021426/0001193125-20-021426-index.htm
2020-01-31S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1055726/000119312520021435/0001193125-20-021435-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520028310/0001193125-20-028310-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520028334/0001193125-20-028334-index.htm
2020-02-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312520029793/0001193125-20-029793-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520065842/0001193125-20-065842-index.htm
2020-03-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520065907/0001193125-20-065907-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1055726/000119312520072995/0001193125-20-072995-index.htm
2020-03-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312520088806/0001193125-20-088806-index.htm
2020-04-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520098301/0001193125-20-098301-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520098305/0001193125-20-098305-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520099003/0001193125-20-099003-index.htm
2020-04-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1055726/000119312520108190/0001193125-20-108190-index.htm
2020-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312520119137/0001193125-20-119137-index.htm
2020-05-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520140456/0001193125-20-140456-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520140512/0001193125-20-140512-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520145017/0001193125-20-145017-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520159486/0001193125-20-159486-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520179128/0001193125-20-179128-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520239111/0001193125-20-239111-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520256781/0001193125-20-256781-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520270257/0001193125-20-270257-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000121465920001194/0001214659-20-001194-index.htm
2018-06-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1055726/999999999518001464/9999999995-18-001464-index.htm
2020-02-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1055726/999999999520000352/9999999995-20-000352-index.htm
2020-03-31EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1055726/999999999520000654/9999999995-20-000654-index.htm

Inovio Pharmaceuticals, Inc (INO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inovio Pharmaceuticals, Inc (INO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 217%
Institutional Ownership: 3649%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-09PETER KIESCFOBuy25,000.00104,354.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm
2018-12-06AVTAR S DHILLONDirectorBuy25,000.002.0050,000.00106,002.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/0001055726-18-000049-index.htm
2019-06-03Jong Joseph KimChief Executive OfficerSell832,848.002.301,914,467.701,078,207.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2019-03-05Mark BagarazziChief Medical OfficerBuy27,567.00109,080.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000009/0001055726-19-000009-index.htm
2020-01-13Jong Joseph KimChief Executive OfficerBuy22,500.003.1169,975.001,100,707.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/0001055726-20-000002-index.htm
2019-05-31Jong Joseph KimChief Executive OfficerSell500,000.002.401,200,800.001,113,232.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2019-03-10PETER KIESCFOBuy20,433.00116,196.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm
2020-07-30Jong Joseph KimChief Executive OfficerSell100,000.0021.132,113,450.001,188,313.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/0001055726-20-000045-index.htm
2020-06-30PETER KIESCFOSell35,000.0026.50927,500.00119,290.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm
2020-07-15PETER KIESCFOSell35,000.0024.95873,208.00119,290.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm
2020-05-08Lota S. ZothDirectorBuy8,013.0012,103.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000028/0001055726-20-000028-index.htm
2020-03-05Jong Joseph KimChief Executive OfficerBuy120,100.001,220,807.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm
2019-05-11WENDY L YARNODirectorBuy8,170.0012,260.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000041/0001055726-19-000041-index.htm
2020-05-08Ann Calby MillerDirectorBuy8,013.0012,287.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000025/0001055726-20-000025-index.htm
2020-03-08Jong Joseph KimChief Executive OfficerBuy63,700.001,247,136.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm
2020-03-10Jong Joseph KimChief Executive OfficerBuy105,700.001,325,139.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/0001055726-20-000017-index.htm
2020-03-05PETER KIESCFOBuy27,567.00136,697.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm
2020-03-08PETER KIESCFOBuy21,467.00148,347.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm
2020-07-15PETER KIESCFOBuy35,000.002.4084,000.00154,290.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm
2018-05-12MORTON COLLINSDirectorBuy7,669.00159,960.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000030/0001055726-18-000030-index.htm
2019-05-16Jong Joseph KimChief Executive OfficerSell61,212.003.50214,242.001,613,232.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm
2020-03-10PETER KIESCFOBuy20,433.00161,356.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/0001055726-20-000014-index.htm
2019-12-05WENDY L YARNODirectorBuy4,090.0016,350.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000059/0001055726-19-000059-index.htm
2020-03-25Jacqueline Elizabeth SheaChief Operating OfficerBuy16,667.0016,667.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/0001055726-20-000019-index.htm
2019-05-15Jong Joseph KimChief Executive OfficerSell75,556.003.50264,446.001,674,444.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm
2019-05-11MORTON COLLINSDirectorBuy8,170.00168,130.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000037/0001055726-19-000037-index.htm
2019-05-31Jong Joseph KimChief Executive OfficerSell500,000.002.441,217,650.001,911,055.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2018-05-12ADEL MAHMOUDDirectorBuy7,669.0022,669.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000032/0001055726-18-000032-index.htm
2018-04-12Jong Joseph KimChief Executive OfficerSell103,750.005.14533,140.132,291,807.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-04-13Jong Joseph KimChief Executive OfficerSell107,500.005.06543,412.502,291,807.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-09-12Jong Joseph KimChief Executive OfficerSell49,060.005.37263,452.202,308,494.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm
2018-05-08Jong Joseph KimChief Executive OfficerBuy23,333.002,315,140.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/0001055726-18-000027-index.htm
2018-09-12Jong Joseph KimChief Executive OfficerBuy49,060.005.08249,224.802,357,554.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm
2018-04-12Jong Joseph KimChief Executive OfficerBuy103,750.002.40249,000.002,395,557.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-04-13Jong Joseph KimChief Executive OfficerBuy107,500.002.16232,200.002,399,307.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2019-05-21Jong Joseph KimChief Executive OfficerSell100,000.003.31331,000.002,411,055.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/0001055726-19-000044-index.htm
2019-03-05Jong Joseph KimChief Executive OfficerBuy120,100.002,428,594.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/0001055726-19-000007-index.htm
2020-05-08WENDY L YARNODirectorBuy8,013.0024,363.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000027/0001055726-20-000027-index.htm
2019-03-09Jong Joseph KimChief Executive OfficerBuy57,333.002,451,788.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm
2019-03-09Laurent HumeauChief Scientific OfficerBuy2,666.0024,867.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm
2019-03-10Jong Joseph KimChief Executive OfficerBuy105,700.002,541,159.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm
2019-03-10Laurent HumeauChief Scientific OfficerBuy2,812.0026,781.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm
2018-04-12SIMON X BENITODirectorSell3,750.005.2319,618.8827,798.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm
2018-04-12SIMON X BENITODirectorBuy3,750.003.5613,350.0031,548.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm
2018-05-12SIMON X BENITODirectorBuy7,669.0035,467.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000029/0001055726-18-000029-index.htm
2020-01-03Lota S. ZothDirectorBuy4,090.004,090.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000001/0001055726-20-000001-index.htm
2018-12-05WENDY L YARNODirectorBuy4,090.004,090.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000048/0001055726-18-000048-index.htm
2020-03-21Ann Calby MillerDirectorBuy4,274.004,274.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000018/0001055726-20-000018-index.htm
2019-05-11SIMON X BENITODirectorBuy8,170.0043,637.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000040/0001055726-19-000040-index.htm
2020-08-10Laurent HumeauChief Scientific OfficerSell19,467.0019.06371,004.0343,966.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/0001055726-20-000049-index.htm
2019-06-05Laurent HumeauChief Scientific OfficerBuy20,000.002.5050,000.0045,833.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/0001055726-19-000047-index.htm
2019-08-30Laurent HumeauChief Scientific OfficerBuy4,500.002.229,990.0050,333.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/0001055726-19-000056-index.htm
2020-05-08SIMON X BENITODirectorBuy8,013.0051,650.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000029/0001055726-20-000029-index.htm
2020-05-20SIMON X BENITODirectorSell8,750.0015.95139,594.0051,650.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm
2018-05-12Angel CabreraDirectorBuy7,669.0059,419.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000033/0001055726-18-000033-index.htm
2020-05-20SIMON X BENITODirectorBuy8,750.004.6040,250.0060,400.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm
2018-07-10PETER KIESCFOSell10,000.004.4544,500.0062,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm
2018-11-29PETER KIESCFOSell10,001.005.2852,805.2862,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm
2020-06-22Laurent HumeauChief Scientific OfficerSell19,467.0014.70286,164.9063,433.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/0001055726-20-000042-index.htm
2019-05-11Angel CabreraDirectorBuy8,170.0067,589.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000039/0001055726-19-000039-index.htm
2018-07-09PETER KIESCFOSell25,000.004.43110,750.0072,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm
2018-11-29PETER KIESCFOBuy10,001.002.0020,002.0072,089.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm
2020-05-08Angel CabreraDirectorBuy8,013.0075,602.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000024/0001055726-20-000024-index.htm
2018-04-16David B. WeinerDirectorSell9,000.004.9144,202.60758,956.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000023/0001055726-18-000023-index.htm
2018-05-12David B. WeinerDirectorBuy7,669.00766,625.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000034/0001055726-18-000034-index.htm
2019-03-05David B. WeinerDirectorBuy11,667.00778,292.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000008/0001055726-19-000008-index.htm
2020-03-05Laurent HumeauChief Scientific OfficerBuy27,567.0077,900.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm
2019-03-09David B. WeinerDirectorBuy5,333.00783,625.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2019-03-09David B. WeinerDirectorBuy10,000.00793,625.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2019-08-01David B. WeinerDirectorSell16,352.002.7244,477.44797,110.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/0001055726-19-000049-index.htm
2019-03-10David B. WeinerDirectorBuy11,667.00805,292.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2020-03-05David B. WeinerDirectorBuy11,667.00808,777.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2018-05-12AVTAR S DHILLONDirectorBuy7,669.0081,002.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/0001055726-18-000028-index.htm
2019-05-11David B. WeinerDirectorBuy8,170.00813,462.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/0001055726-19-000038-index.htm
2019-06-03Jong Joseph KimChief Executive OfficerSell296,705.002.31684,735.80816,527.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2020-03-09David B. WeinerDirectorSell3,500.0018.0063,000.00816,944.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2020-03-08David B. WeinerDirectorBuy11,667.00820,444.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2020-03-12David B. WeinerDirectorSell3,500.0011.1438,990.00821,610.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-03-10David B. WeinerDirectorSell3,500.009.3232,620.00825,110.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-05-11David B. WeinerDirectorSell2,404.0011.8428,463.36827,219.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/0001055726-20-000033-index.htm
2020-03-10David B. WeinerDirectorBuy11,666.00828,610.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-05-08David B. WeinerDirectorBuy8,013.00829,623.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/0001055726-20-000026-index.htm
2020-03-10Laurent HumeauChief Scientific OfficerBuy2,812.0083,873.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/0001055726-20-000015-index.htm
2020-03-08Laurent HumeauChief Scientific OfficerBuy19,900.0087,943.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm
2019-03-05PETER KIESCFOBuy27,567.0089,655.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000006/0001055726-19-000006-index.htm
2018-07-09PETER KIESCFOBuy15,000.004.2463,600.0097,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm